These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 23888685

  • 41. Co-amorphization of atorvastatin by lisinopril as a co-former for solubility improvement.
    Li W, Song J, Li J, Li M, Tian B, He Z, Liu X, Fu Q.
    Int J Pharm; 2021 Sep 25; 607():120971. PubMed ID: 34363915
    [Abstract] [Full Text] [Related]

  • 42. Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen-cimetidine mixtures prepared by mechanical activation.
    Allesø M, Chieng N, Rehder S, Rantanen J, Rades T, Aaltonen J.
    J Control Release; 2009 May 21; 136(1):45-53. PubMed ID: 19331842
    [Abstract] [Full Text] [Related]

  • 43. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P, Graeser K, Gordon KC, Strachan CJ, Rades T.
    Int J Pharm; 2011 Sep 30; 417(1-2):94-100. PubMed ID: 21182910
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films.
    Paudel A, Nies E, Van den Mooter G.
    Mol Pharm; 2012 Nov 05; 9(11):3301-17. PubMed ID: 23009610
    [Abstract] [Full Text] [Related]

  • 47. Application of a Salt Coformer in a Co-Amorphous Drug System Dramatically Enhances the Glass Transition Temperature: A Case Study of the Ternary System Carbamazepine, Citric Acid, and l-Arginine.
    Ueda H, Wu W, Löbmann K, Grohganz H, Müllertz A, Rades T.
    Mol Pharm; 2018 May 07; 15(5):2036-2044. PubMed ID: 29630842
    [Abstract] [Full Text] [Related]

  • 48. Anomalous role change of tertiary amino and ester groups as hydrogen acceptors in eudragit E based solid dispersion depending on the concentration of naproxen.
    Ueda H, Wakabayashi S, Kikuchi J, Ida Y, Kadota K, Tozuka Y.
    Mol Pharm; 2015 Apr 06; 12(4):1050-61. PubMed ID: 25654583
    [Abstract] [Full Text] [Related]

  • 49. The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.
    Milne M, Liebenberg W, Aucamp M.
    AAPS PharmSciTech; 2015 Oct 06; 16(5):1190-202. PubMed ID: 25732372
    [Abstract] [Full Text] [Related]

  • 50. A theoretical and spectroscopic study of co-amorphous naproxen and indomethacin.
    Löbmann K, Laitinen R, Grohganz H, Strachan C, Rades T, Gordon KC.
    Int J Pharm; 2013 Aug 30; 453(1):80-7. PubMed ID: 22613066
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Aspartame as a co-former in co-amorphous systems.
    Wu W, Löbmann K, Schnitzkewitz J, Knuhtsen A, Pedersen DS, Grohganz H, Rades T.
    Int J Pharm; 2018 Oct 05; 549(1-2):380-387. PubMed ID: 30075253
    [Abstract] [Full Text] [Related]

  • 57. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
    Liu X, Zhou L, Zhang F.
    Mol Pharm; 2017 Mar 06; 14(3):658-673. PubMed ID: 28135108
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
    Karmwar P, Boetker JP, Graeser KA, Strachan CJ, Rantanen J, Rades T.
    Eur J Pharm Sci; 2011 Oct 09; 44(3):341-50. PubMed ID: 21884789
    [Abstract] [Full Text] [Related]

  • 60. Co-Amorphous Combination of Nateglinide-Metformin Hydrochloride for Dissolution Enhancement.
    Wairkar S, Gaud R.
    AAPS PharmSciTech; 2016 Jun 09; 17(3):673-81. PubMed ID: 26314243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.